Advertisement
Canada markets open in 1 hour 32 minutes
  • S&P/TSX

    24,822.54
    +132.04 (+0.53%)
     
  • S&P 500

    5,864.67
    +23.20 (+0.40%)
     
  • DOW

    43,275.91
    +36.81 (+0.09%)
     
  • CAD/USD

    0.7237
    -0.0010 (-0.14%)
     
  • CRUDE OIL

    70.84
    +1.62 (+2.34%)
     
  • Bitcoin CAD

    94,215.58
    -332.41 (-0.35%)
     
  • XRP CAD

    0.76
    +0.02 (+2.25%)
     
  • GOLD FUTURES

    2,752.00
    +22.00 (+0.81%)
     
  • RUSSELL 2000

    2,276.09
    -4.76 (-0.21%)
     
  • 10-Yr Bond

    4.0730
    -0.0230 (-0.56%)
     
  • NASDAQ futures

    20,351.00
    -132.50 (-0.65%)
     
  • VOLATILITY

    19.13
    +1.10 (+6.10%)
     
  • FTSE

    8,339.12
    -19.13 (-0.23%)
     
  • NIKKEI 225

    38,954.60
    -27.15 (-0.07%)
     
  • CAD/EUR

    0.6664
    -0.0002 (-0.03%)
     

Ardelyx: Q2 Earnings Snapshot

WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Ardelyx Inc. (ARDX) on Thursday reported a loss of $16.5 million in its second quarter.

On a per-share basis, the Waltham, Massachusetts-based company said it had a loss of 7 cents.

The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 10 cents per share.

The biotechnology company posted revenue of $73.2 million in the period, also surpassing Street forecasts. Six analysts surveyed by Zacks expected $55.7 million.

Ardelyx shares have fallen 11% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $5.50, a climb of 43% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARDX at https://www.zacks.com/ap/ARDX